Savaria Stock Forecast for 2023 - 2025 - 2030
Updated on 05/03/2024
Savaria Stock Forecast and Price Target
The average price target for Savaria's stock lately set by several renowned analysts is C$22.50, which would result in a potential upside of approximately 33.85% if it reaches this mark by December 31, 2024. This estimation is based on a high estimate of C$23.50 and a low estimate of C$19.00. If you are interested in SIS stock, you should also look at its competitors.
33.85% Upside
Savaria Fair Value Forecast for 2023 - 2025 - 2030
In the last four years, Savaria's Price has decreased from C$15.88 to C$0.00 – a 100.00% drop. For next year, analysts predict Fair Value of C$23.82, which would mean an increase of 100.00%. Over the next seven years, experts predict that Savaria's Fair Value will grow at a rate of 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| EW Stock Forecast | Edwards Lifesciences Corp | Outperform |
11
|
$85.06 | Buy/Sell | $91.18 | 16.39% |
| RMD Stock Forecast | ResMed Inc | Outperform |
17
|
$218.15 | Buy/Sell | $201.32 | 0.62% |
| WST Stock Forecast | West Pharmaceutical Services | Outperform |
18
|
$368.46 | Buy/Sell | $380.80 | 7.20% |
| STE Stock Forecast | STERIS | Outperform |
13
|
$206.24 | Buy/Sell | $238.33 | 16.86% |
| HOLX Stock Forecast | Hologic | Outperform |
8
|
$75.91 | Buy/Sell | $81.06 | 11.32% |
Savaria Revenue Forecast for 2023 - 2025 - 2030
In the last two years, Savaria's Revenue has grown by 122.59%, rising from C$354.50M to C$789.09M. For next year, analysts predict Revenue of C$892.84M, which would mean an increase of 13.15%. Over the next seven years, experts predict that Savaria's Revenue will grow at a rate of 10.26%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| COO Stock Forecast | The Cooper Companies | Outperform |
13
|
$89.75 | Buy/Sell | $391.40 | 22.56% |
| TFX Stock Forecast | Teleflex Inc | Hold |
13
|
$198.73 | Buy/Sell | $263.46 | 33.35% |
| MD Stock Forecast | Pediatrix Medical Group | Hold |
12
|
$9.12 | Buy/Sell | $9.86 | -1.32% |
.jpg)
Savaria Dividend per Share Forecast for 2023 - 2025 - 2030
In the last two years, Savaria's Dividend per Share has grown by 10.87%, rising from C$0.46 to C$0.51. For next year, analysts predict Dividend per Share of C$0.53, which would mean an increase of 3.92%. Over the next seven years, experts predict that Savaria's Dividend per Share will grow at a rate of 3.25%.
Savaria EBITDA Forecast for 2023 - 2025 - 2030
Savaria's EBITDA has grown In the last two years, rising from C$51.94M to C$99.25M – a growth of 91.09%. In the next year, analysts believe that EBITDA will reach C$149.04M – an increase of 50.17%. For the next seven years, experts predict that Savaria's EBITDA will grow at a rate of 77.78%.
Savaria EBIT Forecast for 2023 - 2025 - 2030
Savaria's EBIT has seen impressive growth In the last two years, rising from C$41.40M to C$69.26M – a growth of 67.29%. In the next year, analysts believe that EBIT will reach C$93.10M – an increase of 34.42%. For the next seven years, the forecast is for EBIT to grow by 26.89%.
Savaria EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last four years, Savaria's EPS has decreased from C$0.56 to C$0.00 – a 100.00% drop. For next year, analysts predict EPS of C$0.84, which would mean an increase of 100.00%. Over the next seven years, experts predict that Savaria's EPS will grow at a rate of 100.00%.
.jpg)